Aperio Group’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-7,659
| Closed | -$312K | – | 2339 |
|
|
2020
Q1 | $312K | Buy |
7,659
+1,049
| +16% | +$42.7K | ﹤0.01% | 1882 |
|
|
2019
Q4 | $407K | Sell |
6,610
-211
| -3% | -$13K | ﹤0.01% | 1919 |
|
|
2019
Q3 | $497K | Sell |
6,821
-199
| -3% | -$14.5K | ﹤0.01% | 1762 |
|
|
2019
Q2 | $577K | Buy |
7,020
+664
| +10% | +$54.6K | ﹤0.01% | 1698 |
|
|
2019
Q1 | $449K | Sell |
6,356
-51
| -0.8% | -$3.6K | ﹤0.01% | 1807 |
|
|
2018
Q4 | $288K | Buy |
6,407
+1,000
| +18% | +$45K | ﹤0.01% | 1969 |
|
|
2018
Q3 | $306K | Sell |
5,407
-392
| -7% | -$22.2K | ﹤0.01% | 2001 |
|
|
2018
Q2 | $387K | Buy |
5,799
+1,019
| +21% | +$68K | ﹤0.01% | 1876 |
|
|
2018
Q1 | $278K | Buy |
4,780
+914
| +24% | +$53.2K | ﹤0.01% | 1986 |
|
|
2017
Q4 | $249K | Buy |
+3,866
| New | +$249K | ﹤0.01% | 2049 |
|
|
2017
Q1 | – | Sell |
-3,349
| Closed | -$203K | – | 2143 |
|
|
2016
Q4 | $203K | Buy |
3,349
+278
| +9% | +$16.9K | ﹤0.01% | 1999 |
|
|
2016
Q3 | $204K | Buy |
+3,071
| New | +$204K | ﹤0.01% | 1926 |
|